WELL Stock Analysis — Welltower
Sector: Healthcare REIT
AI Verdict
Welltower trades at 71.6x next year's earnings with 47.5% growth expected—you're paying a steep premium that only makes sense if its scale and demographic moat deliver flawless execution.
Competitive Moat
Welltower owns and operates a vast network of senior housing and healthcare properties, benefiting from scale and long-term operator relationships that are difficult for new entrants to replicate. Its portfolio is positioned to capture demographic tailwinds as the aging population drives demand for senior care facilities.
Summary
Welltower's 47.5% expected EPS growth and 43.87% one-year return have pushed its forward P/E to 71.6x, making it one of the most expensive names in healthcare real estate.
Where It Stands
With a 1-year return of 43.87%, an RSI of 60.4 (neutral), and a forward P/E of 71.6x versus the healthcare sector median of 22x, the stock is priced for aggressive growth.
Key Metrics
- RSI: 60.4 — Near Overbought
- Trailing P/E: 105.7x
- Forward P/E: 71.6x
- PEG Ratio: 2.22
- Earnings Growth: +0.5%
- Revenue Growth: +0.4%
- Market Cap: $151.5B
- Dividend Yield: 0.01%
- 1-Year Return: 43.87%
- 52-Week High: $219.59
- 52-Week Low: $142.65
Analyst Consensus
22 Buy · 4 Hold · 0 Sell (26 analysts)
Bull Case
Analysts expect 47.5% EPS growth next year, which, if delivered, could justify the current 71.6x forward P/E for investors betting on sustained demographic-driven demand.
Bear Case
If the P/E reverts even halfway toward the sector median (from 71.6x to 46x), the stock could lose over 35% of its value even if earnings grow as forecast.
Catalyst to Watch
Quarterly occupancy and rent growth updates will show whether Welltower is actually capturing the projected earnings surge.